Health
Heparin targets coronavirus spike protein, research shows – Newswise
An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant
Newswise — An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by reducing the virus’ ability to attach to human cells and infect them.
The research, published in the journals British Journal of Pharmacology, and Thrombosis and Haemostasis, found that heparin interacts with the spike protein on the surface of coronavirus (SARS-CoV2),…
-
General20 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Business14 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business10 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News9 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred